Literature DB >> 34887547

Safety and efficacy of COVID-19 vaccines in people with neurological disorders.

Heather Wood1.   

Abstract

Entities:  

Year:  2022        PMID： 34887547      PMCID： PMC8655711          DOI： 10.1038/s41582-021-00603-8

Source DB:  PubMed          Journal:  Nat Rev Neurol        ISSN： 1759-4758            Impact factor:   42.937


× No keyword cloud information.
  2 in total

1.  mRNA intramuscular vaccination produces a robust IgG antibody response in advanced neuromuscular disease.

Authors:  Alexis R Demonbreun; Matthew P Velez; Rana Saber; Daniel T Ryan; Amelia Sancilio; Thomas W McDade; Elizabeth M McNally
Journal:  Neuromuscul Disord       Date:  2021-11-19       Impact factor: 4.296

2.  COVID-19 vaccine take-up rate and safety in adults with epilepsy: Data from a multicenter study in China.

Authors:  Lu Lu; Qi Zhang; Jing Xiao; Yingying Zhang; Wei Peng; Xiong Han; Shengli Chen; Dan Yang; Josemir W Sander; Dong Zhou; Weixi Xiong
Journal:  Epilepsia       Date:  2021-11-21       Impact factor: 5.864
  2 in total
  1 in total

1.  Discovering COVID-19 state sustainable policies for mitigating and ending the pandemic.

Authors:  Yoshiyasu Takefuji
Journal:  Cities       Date:  2022-07-06
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.